INQ000409529 – Minutes of the Commission on Human Medicines and Covid-19 Vaccines Benefit Risk Expert Working Group meeting regarding COM-COV Trial immunogenicity data, Update review on myocarditis and pericarditis and the risk of thromboembolic events following the COVID-19 vaccine, dated 21/06/2021.

  • Published: 8 September 2025
  • Type: Evidence
  • Module: Module 4

Minutes of the Commission on Human Medicines and Covid-19 Vaccines Benefit Risk Expert Working Group meeting regarding COM-COV Trial immunogenicity data, Update review on myocarditis and pericarditis and the risk of thromboembolic events following the COVID-19 vaccine, dated 21/06/2021.

Download this document